CA ATC C08DB01 · updated 2 Nov 2026
Diltiazem shortage in Canada
Is there a Diltiazem shortage in Canada?
Yes. As of 2 Nov 2026, 23 Diltiazem products are reported short in Canada, the first since 10 Mar 2017. The company estimate for the return is 10 Nov 2026 (latest 31 May 2027). Main reason: manufacturing problem.
Also short in Germany, Italy, Spain, Austria, Belgium, Japan. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | APO-DILTIAZ SR - 90MG/SRC (100 BTL & 500 BTL) | APOTEX INC | 10 Mar 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-DILTIAZ SR - SRC 120MG (100 BTL & 500 BTL) | APOTEX INC | 10 Mar 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-DILTIAZ SR - SRC 60MG (100 BTL & 500 BTL) | APOTEX INC | 10 Mar 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-DILTIAZEM (100) | TEVA CANADA LIMITED | 1 Mar 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ACT DILTIAZEM CD (100) | TEVA CANADA LIMITED | 1 Dec 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP DILTIAZEM CD (100) | JAMP PHARMA CORPORATION | 12 Mar 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-DILTIAZ CD (100 BTL) | APOTEX INC | 17 Mar 2026 | 31 May 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-DILTIAZ CD (100 BTL) | APOTEX INC | 31 Mar 2026 | 31 May 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP DILTIAZEM CD (Bottle 100) | JAMP PHARMA CORPORATION | 21 Apr 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | DILTIAZEM HYDROCHLORIDE INJECTION (10 x 5 mL vial / fiole) | OMEGA LABORATORIES LIMITED | 1 May 2026 | 31 Mar 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | DILTIAZEM CD (100) | SIVEM PHARMACEUTICALS ULC | 6 Jun 2026 | 1 May 2027 | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | APO-DILTIAZ CD (100 BTL) | APOTEX INC | 9 Jun 2026 | 31 May 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-DILTIAZEM CD (100) | TEVA CANADA LIMITED | 10 Jun 2026 | 10 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | DILTIAZEM CD (100) | SIVEM PHARMACEUTICALS ULC | 15 Jun 2026 | 1 May 2027 | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | PRO-DILTIAZEM CD (100) | PRO DOC LIMITEE | 3 Aug 2026 | 15 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | DILTIAZEM CD (100) | SANIS HEALTH INC | 5 Aug 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-DILTIAZ CD (100 BTL) | APOTEX INC | 25 Aug 2026 | 31 May 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PRO-DILTIAZEM CD (100) | PRO DOC LIMITEE | 27 Aug 2026 | 15 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PRO-DILTIAZEM CD (100) | PRO DOC LIMITEE | 28 Aug 2026 | 15 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PRO-DILTIAZEM CD (100) | PRO DOC LIMITEE | 8 Sep 2026 | 15 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | DILTIAZEM CD (100) | SANIS HEALTH INC | 5 Oct 2026 | 13 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | M-DILTIAZEM CD (Bottle of 100 tablets) | MANTRA PHARMA INC | 19 Oct 2026 | 15 Dec 2026 | Distribution or logistics Delay in shipping of the drug |
| CA | MAR-DILTIAZEM CD (BOTTLE X 100 CAPS) | MARCAN PHARMACEUTICALS INC | 20 Oct 2026 | 31 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.